A Comparison of Cardiovascular Benefits of Dapagliflozin and Empagliflozin in Type 2 Diabetes: A Systematic Review and Meta-analysis

Date

2025

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Abstract

Description

Keywords

Dapagliflozin, Empagliflozin, Medicine, Internal medicine, Diabetes mellitus, Type 2 diabetes, Heart failure, Myocardial infarction, Population, Stroke (engine)

Citation

DOI

10.1007/s42399-025-02103-y

URI

https://doi.org/10.1007/s42399-025-02103-y
 https://andeanlibrary.org/handle/123456789/78036

Collections

Artículo Científico Publicado